Fibrosis Changes in the Placebo Arm of NASH Clinical Trials.

Altayar, Osama; Noureddin, Nabil; Thanda Han, Ma Ai; Murad, M Hassan; Noureddin, Mazen

Altayar, Osama; Noureddin, Nabil; Thanda Han, Ma Ai; Murad, M Hassan; Noureddin, Mazen.

Afiliação

Altayar O; Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri.
Noureddin N; Department of Internal Medicine, University of Nevada, Las Vegas, Nevada.
Thanda Han MA; Division of Digestive and Liver Diseases, Cedars Sinai Medical Center, Los Angeles, California.
Murad MH; Evidence-based Practice Center, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
Noureddin M; Fatty Liver Program, Division of Digestive and Liver Diseases, Comprehensive Transplant Program, Cedars Sinai Medical Center, Los Angeles, California.

Clin Gastroenterol Hepatol ; 17(11): 2387, 2019 10.

Article em En | MEDLINE | ID: mdl-31543242

Assuntos

Hepatopatia Gordurosa não Alcoólica; Fibrose; Humanos; Cirrose Hepática

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google